BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20648612)

  • 1. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A; Magri MC; Manuel RC
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
    Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
    J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
    Biggar RJ; Engels EA; Whitby D; Kedes DH; Goedert JJ
    J Infect Dis; 2003 Jan; 187(1):12-8. PubMed ID: 12508141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: potential for endemic and epidemic Kaposi's sarcoma.
    Caterino-de-Araujo A; Manuel RC; Del Bianco R; Santos-Fortuna E; Magri MC; Silva JM; Bastos R
    J Med Virol; 2010 Jul; 82(7):1216-23. PubMed ID: 20513087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
    N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma.
    Martro E; Bulterys M; Stewart JA; Spira TJ; Cannon MJ; Thacher TD; Bruns R; Pellett PE; Dollard SC
    J Med Virol; 2004 Jan; 72(1):126-31. PubMed ID: 14635020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
    Szalai E; Gerlei Z; Szlávik J; Szládek G; Patel R; Hunyadi J; Gergely L; Juhász A
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):265-8. PubMed ID: 15681157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
    Katano H; Sato Y; Kurata T; Mori S; Sata T
    Virology; 2000 Apr; 269(2):335-44. PubMed ID: 10753712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual transmission and the natural history of human herpesvirus 8 infection.
    Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
    N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.
    Plancoulaine S; Abel L; Trégouët D; Duprez R; van Beveren M; Tortevoye P; Froment A; Gessain A
    Cancer Res; 2004 Dec; 64(23):8782-7. PubMed ID: 15574792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
    Okroj M; Tedeschi R; Mancuso R; Brambilla L; Tourlaki A; Dillner J; Blom AM
    Vaccine; 2011 Feb; 29(6):1129-34. PubMed ID: 21134448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET; Blackbourn DJ; Levy JA
    Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
    Tanzi E; Zappa A; Caramaschi F; Amendola A; Lasagna D; Gatti L; Ascoli V; Rezza G; Zanetti AR
    J Med Virol; 2005 Aug; 76(4):571-5. PubMed ID: 15977229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.